July 10, 2025

HHS Scraps Preventive Care Panel Meeting

HHS unexpectedly canceled a meeting of the U.S. Preventive Services Task Force, prompting fears it may be dismantled following similar moves by Secretary Robert F. Kennedy Jr. at other federal health agencies.

Conexiant

July 10, 2025

No Heart Risk Found With Triptan Use

A large real-world study found no significant increase in short-term heart attack or stroke risk among migraine patients using triptans, including those with cardiovascular risk factors.

Conexiant

July 09, 2025

Once-Weekly Combo Injection Cuts Weight by 20% 

A large 68-week clinical trial found that a once-weekly combination injection of cagrilintide and semaglutide led to significant and sustained weight loss in adults with overweight or obesity, with over half achieving at least 20% weight reduction.

Conexiant

July 09, 2025

ESC: Vaccines May Prevent Major Heart Events

A new ESC clinical statement finds that common vaccines, including those for influenza and COVID-19, may lower cardiovascular risks such as heart attack, stroke, and heart failure, particularly in high-risk patients.

Conexiant

July 09, 2025

Evening Dosing Lowers BP Better, Study Finds

Researchers found that bedtime dosing of olmesartan-amlodipine improved nocturnal blood pressure control without increasing adverse events in patients with hypertension.

Conexiant

July 09, 2025

Better Cholesterol Treatment Could Prevent Thousands of Cardiovascular Events

New research using US national survey data found that most adults with high LDL cholesterol are not receiving recommended treatments, and fully following clinical guidelines could prevent hundreds of thousands of cardiovascular events and reduce healthcare costs by billions annually.

Conexiant

July 08, 2025

Waist Size Plus BMI Predicts Mortality

A major long-term study of postmenopausal women found that waist circumference, when assessed alongside BMI, improved mortality risk prediction compared with BMI alone.

Conexiant

July 08, 2025

Mediterranean Diet’s 30-Year Legacy

A sweeping 30-year review confirms the Mediterranean-style diet lowers risks of heart disease, diabetes, cancer, and cognitive decline—while supporting global sustainability.

Conexiant

July 08, 2025

Orforglipron Lowers A1c, Weight in T2D Patients 

A 40-week trial presented at ADA's 85th Scientific Sessions showed that daily oral orforglipron significantly lowered blood sugar and body weight in adults with early type 2 diabetes.

Conexiant